ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank78
3Y CAGR-20.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-20.3%/yr
vs +93.0%/yr prior
Acceleration
-113.2pp
Decelerating
Percentile
P78
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.47% |
| Q3 2025 | 18.58% |
| Q2 2025 | 5.90% |
| Q1 2025 | -16.83% |
| Q4 2024 | 2.58% |
| Q3 2024 | -12.38% |
| Q2 2024 | 15.58% |
| Q1 2024 | -25.07% |
| Q4 2023 | -23.54% |
| Q3 2023 | 7.09% |
| Q2 2023 | -2.51% |
| Q1 2023 | -34.57% |
| Q4 2022 | 20.66% |
| Q3 2022 | -8.69% |
| Q2 2022 | 21.75% |
| Q1 2022 | -39.51% |
| Q4 2021 | -34.11% |
| Q3 2021 | 26.65% |
| Q2 2021 | -11.09% |
| Q1 2021 | 16.40% |
| Q4 2020 | -86.06% |
| Q3 2020 | 0.04% |
| Q2 2020 | -15.76% |
| Q1 2020 | -15.82% |
| Q4 2019 | -33.36% |
| Q3 2019 | 2.44% |
| Q2 2019 | 0.67% |
| Q1 2019 | 0.00% |